Cardiology

Levetiracetam may reduce anticoagulation effect of rivaroxaban

Levetiracetam, a commonly used medication to prevent seizures, may reduce the anticoagulation effect of oral rivaroxaban in humans. As such, clinicians should measure direct oral anticoagulant plasma levels during treatment. ...

Medications

Antiepileptic drugs not tied to dementia risk

(HealthDay)—Antiepileptic drug (AED) use is not significantly associated with dementia risk in patients in Germany, according to a study published online March 12 in the Journal of Alzheimer's Disease.

Neuroscience

Review: Levetiracetam best monotherapy for partial seizures

(HealthDay)—Levetiracetam performs better than carbamazepine and lamotrigine for individuals with partial seizures, according to a review and meta-analysis published online June 29 in the Cochrane Library.

Medications

Research team launches groundbreaking drug trial in Africa

Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy ...

page 1 from 2

Levetiracetam

Levetiracetam (INN) ( /lɛvɨtɪˈræsɨtæm/) is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.

Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. Since November of 2008 the drug has been available as a generic brand in the United States.

This text uses material from Wikipedia, licensed under CC BY-SA